{"id":123388,"date":"2026-09-08T11:14:59","date_gmt":"2026-09-08T05:44:59","guid":{"rendered":"https:\/\/vajiramandravi.com\/current-affairs\/?p=123388"},"modified":"2026-09-08T11:14:59","modified_gmt":"2026-09-08T05:44:59","slug":"antimicrobial-resistance-in-india-why-antibiotic-overuse-is-not-the-only-problem","status":"publish","type":"post","link":"https:\/\/vajiramandravi.com\/current-affairs\/antimicrobial-resistance-in-india-why-antibiotic-overuse-is-not-the-only-problem\/","title":{"rendered":"Antimicrobial Resistance in India: Why Antibiotic Overuse Is Not the Only Problem"},"content":{"rendered":"<h2><b>Antimicrobial Resistance in India Latest News<\/b><\/h2>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">A new study by the Indian Council of Medical Research (ICMR) has found that infections caused by <\/span><b>antibiotic-resistant<\/b><span style=\"font-weight: 400;\"> Gram-negative bacteria are deadlier and costlier to treat than infections caused by drug-susceptible strains.\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">India&#8217;s antimicrobial resistance (AMR) crisis goes well beyond antibiotic overuse. Delayed diagnosis, hospital transmission and weak infection control are equally responsible.<\/span><\/li>\n<\/ul>\n<h2><b>Understanding Gram-Negative Bacteria and Carbapenems<\/b><\/h2>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Gram-negative bacteria have a thin peptidoglycan cell wall and an outer membrane containing lipopolysaccharides. They stain pink or red during Gram staining.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">They cause infections in the lungs, urinary tract, wounds and bloodstream. Common hospital pathogens in this group include <strong><a href=\"https:\/\/vajiramandravi.com\/current-affairs\/escherichia-coli\/\" target=\"_blank\">Escherichia coli<\/a><\/strong> (E. coli), Klebsiella pneumoniae, Acinetobacter baumannii and Pseudomonas aeruginosa.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Carbapenems are a powerful class of antibiotics used for serious infections. They are often the last line of defence.\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">When bacteria become resistant to carbapenems, doctors are left with very few effective medicines.<\/span><\/li>\n<\/ul>\n<h2><b>Key Findings of the ICMR Study<\/b><\/h2>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">The study was conducted by ICMR&#8217;s antimicrobial resistance surveillance network across 20 tertiary-care hospitals between April 2022 and April 2025.\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Mortality was consistently higher among patients with carbapenem-resistant infections across all four major pathogens. The relative risk of death was 1.16 to 1.43 times higher.\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">More than 61 per cent of Gram-negative infections in the study were carbapenem-resistant.\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Experts call carbapenem resistance a major threat to patient survival, especially in severe and bloodstream infections. However, they caution against treating resistance as an entirely independent cause of death.\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Severity of illness, timing of treatment, source control and patient factors also shape outcomes. Resistance is best understood as an important marker of excess mortality.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">The study also points to healthcare-associated transmission, invasive devices, recent surgery, antibiotic pressure and gaps in infection prevention and diagnosis.\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">AMR is the product of a complex interaction among these factors. It cannot be reduced to antibiotic overuse alone.<\/span><\/li>\n<\/ul>\n<h2><b>The Hidden Economic Burden<\/b><\/h2>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">The study&#8217;s cost figures are conservative. Researchers looked only at the cost of antibiotics available under the Jan Aushadhi scheme.\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">They excluded ICU charges, bed costs, diagnostics, procedures, supportive care and consultation fees.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Even on this narrow measure, antibiotic costs for resistant infections were 1.1 to 2 times higher. The true burden on patients, families and the healthcare system is likely far greater.<\/span><\/li>\n<\/ul>\n<h2><b>A Signal, Not a Verdict, on Newer Drugs<\/b><\/h2>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">The antibiotic Ceftazidime-avibactam was linked to better outcomes in some resistant E. coli and K. pneumoniae infections, including bloodstream infections. Experts describe this as an important signal rather than proof of superiority.\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">The study was observational and could not fully adjust for disease severity, timing of therapy or resistance mechanisms.\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">The results reflect real-world treatment patterns in India, not a definitive drug ranking.\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">This underlines the need for better diagnostics to guide treatment instead of simply escalating to newer, broader antibiotics.<\/span><\/li>\n<\/ul>\n<h2><b>Antibiotics Cannot Replace Infection Prevention<\/b><\/h2>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">More than 85 per cent of bloodstream infections in the study were healthcare-associated. This shows that Indian hospitals are relying on antibiotics to fix what is essentially an <\/span><b>infection-prevention failure<\/b><span style=\"font-weight: 400;\">.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Hospitals must place <\/span><b>infection prevention and control<\/b><span style=\"font-weight: 400;\"> at the centre of their AMR response.\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">This includes hand hygiene, prevention of device-associated infections, appropriate insertion and early removal of invasive devices, environmental cleaning, surgical infection prevention and surveillance of healthcare-associated infections.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Antimicrobial stewardship is equally vital. The answer to rising resistance is not stronger antibiotics.\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">It is to prevent infections, diagnose them quickly and use the narrowest effective antibiotic for the shortest appropriate duration.<\/span><\/li>\n<\/ul>\n<h2><b>The Way Forward: An Integrated Response<\/b><\/h2>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>First,<\/b><span style=\"font-weight: 400;\"> India must move from isolate-based surveillance to integrated surveillance that links laboratory results with patient outcomes, mortality and treatment.\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Second<\/b><span style=\"font-weight: 400;\">, faster and more accurate diagnostics are needed to distinguish bacterial from non-bacterial illness and detect resistance early.\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Third<\/b><span style=\"font-weight: 400;\">, antimicrobial stewardship must become routine clinical practice, not an optional programme.\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Fourth<\/b><span style=\"font-weight: 400;\">, infection prevention must receive as much attention as prescribing.\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Finally, India needs responsible access to newer antimicrobials, backed by stewardship, so these drugs remain effective when truly needed.<\/span><\/li>\n<\/ul>\n<h2><b>Conclusion<\/b><\/h2>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">The ICMR study confirms that carbapenem resistance is a serious threat to survival and a heavy economic burden. India&#8217;s AMR crisis cannot be solved by discovering a new antibiotic each time an old one fails.\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Preventing infections, diagnosing them early and preserving existing antibiotics must become the core of national health policy.<\/span><\/li>\n<\/ul>\n<p><b>Source:<\/b> <strong><a href=\"https:\/\/indianexpress.com\/article\/explained\/explained-health\/antibiotic-resistance-india-carbapenem-infections-explained-10860130\/\" target=\"_blank\" rel=\"nofollow noopener\">IE<\/a><\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Antimicrobial resistance in India is driven by antibiotic overuse, delayed diagnosis, hospital transmission and weak infection control, increasing mortality and treatment costs.<\/p>\n","protected":false},"author":18,"featured_media":123406,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[18],"tags":[10100,60,22,59],"class_list":["post-123388","post","type-post","status-publish","format-standard","has-post-thumbnail","category-upsc-mains-current-affairs","tag-antimicrobial-resistance-in-india","tag-mains-articles","tag-upsc-current-affairs","tag-upsc-mains-current-affairs","no-featured-image-padding"],"acf":[],"_links":{"self":[{"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/posts\/123388","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/users\/18"}],"replies":[{"embeddable":true,"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/comments?post=123388"}],"version-history":[{"count":4,"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/posts\/123388\/revisions"}],"predecessor-version":[{"id":123401,"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/posts\/123388\/revisions\/123401"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/media\/123406"}],"wp:attachment":[{"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/media?parent=123388"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/categories?post=123388"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/tags?post=123388"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}